162 related articles for article (PubMed ID: 24472400)
1. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin.
Takada M; Fujimoto M; Hosomi K
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):181-91. PubMed ID: 24472400
[TBL] [Abstract][Full Text] [Related]
2. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
[TBL] [Abstract][Full Text] [Related]
3. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
4. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
[TBL] [Abstract][Full Text] [Related]
5. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
Kelly JP; Kaufman DW; Jurgelon JM; Sheehan J; Koff RS; Shapiro S
Lancet; 1996 Nov; 348(9039):1413-6. PubMed ID: 8937281
[TBL] [Abstract][Full Text] [Related]
6. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
7. Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns.
Hedberg J; Sundström J; Thuresson M; Aarskog P; Oldgren J; Bodegard J
J Intern Med; 2013 Oct; 274(4):371-80. PubMed ID: 23800296
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries.
Mo C; Sun G; Lu ML; Zhang L; Wang YZ; Sun X; Yang YS
World J Gastroenterol; 2015 May; 21(17):5382-92. PubMed ID: 25954113
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
10. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
Szabó IL; Mátics R; Hegyi P; Garami A; Illés A; Sarlós P; Bajor J; Szűcs A; Mosztbacher D; Márta K; Szemes K; Csekő K; Kővári B; Rumbus Z; Vincze Á
J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
[TBL] [Abstract][Full Text] [Related]
11. Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy.
Endo H; Sakai E; Higurashi T; Yamada E; Ohkubo H; Iida H; Koide T; Yoneda M; Abe Y; Inamori M; Hosono K; Takahashi H; Kubota K; Nakajima A
Dig Liver Dis; 2012 Oct; 44(10):833-8. PubMed ID: 22749649
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users.
Sugano K
Curr Pharm Des; 2015; 21(35):5082-8. PubMed ID: 26369684
[TBL] [Abstract][Full Text] [Related]
13. Clinical study of upper gastrointestinal bleeding associated with low-dose aspirin in Japanese patients.
Okada K; Inamori M; Imajo K; Chiba H; Nonaka T; Shiba T; Sakaguchi T; Atsukawa K; Takahashi H; Hoshino E; Nakajima A
Hepatogastroenterology; 2009; 56(96):1665-9. PubMed ID: 20214214
[TBL] [Abstract][Full Text] [Related]
14. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS
N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
[No Abstract] [Full Text] [Related]
16. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
[TBL] [Abstract][Full Text] [Related]
17. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
Mielants H; Verbruggen G; Schelstraete K; Veys EM
J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
[TBL] [Abstract][Full Text] [Related]
18. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
[TBL] [Abstract][Full Text] [Related]
19. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
20. Aspirin preparation and risk of GI bleeding.
Rao G
J Fam Pract; 1997 Mar; 44(3):242-3. PubMed ID: 9071237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
